Compounds > gemcitabine
Page last updated: 2024-08-24

gemcitabine and Dihydropyrimidine Dehydrogenase Deficiency

gemcitabine has been researched along with Dihydropyrimidine Dehydrogenase Deficiency in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Black, PC; Contreras-Sanz, A; Eto, M; Hayashi, T; Inokuchi, J; Kang, D; Kiyokoba, R; Kohashi, K; Matsumoto, S; Matsumoto, T; Nagakawa, S; Noda, N; Oda, Y; Setoyama, D; Shiota, M; Takamatsu, D; Tsukahara, S; Uchiumi, T; Yagi, M1

Other Studies

1 other study(ies) available for gemcitabine and Dihydropyrimidine Dehydrogenase Deficiency

ArticleYear
Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine.
    Scientific reports, 2022, 05-20, Volume: 12, Issue:1

    Topics: Deoxycytidine; Dihydropyrimidine Dehydrogenase Deficiency; Dihydrouracil Dehydrogenase (NADP); Gemcitabine; Genomics; Humans; Urinary Bladder Neoplasms

2022